pantoprazole has been researched along with Abnormalities, Congenital in 1 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhong, JW | 1 |
| Yu, LM | 1 |
| Ying, QJ | 1 |
| Peng, WW | 1 |
| Xu, CZ | 1 |
| Cai, ZZ | 1 |
| Xue, ZX | 1 |
| Zhou, YH | 1 |
1 other study available for pantoprazole and Abnormalities, Congenital
| Article | Year |
|---|---|
Performance of endoscopic ultrasound for diagnosis of agenesis of the dorsal pancreas: a case report.
Topics: Aged; Alprostadil; Cholangiopancreatography, Magnetic Resonance; Congenital Abnormalities; Endosonog | 2020 |